OptimizeRx (OPRX) Tax Provisions (2023 - 2026)

OptimizeRx (OPRX) has 4 years of Tax Provisions data on file, last reported at -$149000.0 in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 86.11% year-over-year to -$149000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 497.83% YoY), and the FY2025 full-year result was $1.8 million, up 150.76% from the prior year.
• Tax Provisions declined to -$149000.0 in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.5 million in Q4 2025 to a low of -$1.1 million in Q2 2024.
• A 4-year average of $243800.0 and a median of $107000.0 in 2023 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions plunged 3396.97% in 2024 and surged 133.05% in 2025, its largest moves.
• Tracing OPRX's Tax Provisions over 4 years: stood at $33000.0 in 2023, then jumped by 6827.27% to $2.3 million in 2024, then gained by 7.22% to $2.5 million in 2025, then tumbled by 106.08% to -$149000.0 in 2026.
• Business Quant data shows OPRX's Tax Provisions at -$149000.0 in Q1 2026, $2.5 million in Q4 2025, and $270000.0 in Q3 2025.